Prot #AVM-003-HC: Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR-105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant

Project: Research project

Project Details

StatusActive
Effective start/end date10/28/20 → 10/28/23

Funding

  • Medpace Clinical Research LLC (Prot #AVM-003-HC)
  • AlloVir, Inc (Prot #AVM-003-HC)